BEKADJA MA. OUTCOME OF FRONTLINE TREATMENT WITH “GENERIC” IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY. Mediterr J Hematol Infect Dis [Internet]. 2017 Oct. 25 [cited 2024 Apr. 19];9(1):e2017062. Available from: https://www.mjhid.org/mjhid/article/view/2017.062